{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:08:55Z","timestamp":1789056535338,"version":"build-2803163510"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013061","name":"Jilin Scientific and Technological Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biochi.2026.07.005","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:18:18Z","timestamp":1784042298000},"page":"127-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Advances in antibiotic heteroresistance in Acinetobacter baumannii"],"prefix":"10.1016","volume":"249","author":[{"given":"Xin","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahe","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2026.07.005_bib1","article-title":"The association between undetected heteroresistance and antibiotic treatment failure in complicated urinary tract infection","author":"Abbott","year":"2025","journal-title":"medRxiv"},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijantimicag.2016.09.024","article-title":"Characterisation of successive Acinetobacter baumannii isolates from a deceased haemophagocytic lymphohistiocytosis patient","volume":"49","author":"Choi","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biochi.2026.07.005_bib3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jgar.2019.11.010","article-title":"Heteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from gorgan, northern Iran","volume":"21","author":"Ezadi","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"issue":"9","key":"10.1016\/j.biochi.2026.07.005_bib4","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1128\/AAC.01571-06","article-title":"Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic\/pharmacodynamic model","volume":"51","author":"Tan","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biochi.2026.07.005_bib5","article-title":"Mechanistic insights and clinical implications of cross-reactive anti-prophage antibodies and bacterial heteroresistance on phage therapeutic failure","author":"Gordillo Altamirano","year":"2025","journal-title":"bioRxiv"},{"issue":"11","key":"10.1016\/j.biochi.2026.07.005_bib6","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1093\/jac\/dkw293","article-title":"Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies","volume":"71","author":"Rao","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.biochi.2026.07.005_bib7","first-page":"1103","article-title":"Advances in polymyxin heteroresistance and its clinical significance","volume":"45","author":"Fu","year":"2020","journal-title":"Chin. J. Antibiot."},{"issue":"6","key":"10.1016\/j.biochi.2026.07.005_bib8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/QCO.0000000000000964","article-title":"What is the clinical significance of 'heteroresistance' in nonfermenting Gram-negative strains?","volume":"36","author":"Tiseo","year":"2023","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.biochi.2026.07.005_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cmi.2022.10.018","article-title":"Antibiotic heteroresistance in ESKAPE pathogens, from bench to bedside","volume":"29","author":"Roch","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib10","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2515303123","article-title":"Resistance, heteroresistance, and fitness costs drive colistin treatment failure during Acinetobacter baumannii pneumonia","volume":"123","author":"Hernandez-Bird","year":"2026","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.biochi.2026.07.005_bib11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cmi.2024.01.014","article-title":"Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: a genomic, retrospective cohort study","volume":"30","author":"Luo","year":"2024","journal-title":"Clin. Microbiol. Infection : Off. Public. Eur. Soc. Clini. Microbiol. Infect. Dis."},{"issue":"3","key":"10.1016\/j.biochi.2026.07.005_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41564-018-0342-0","article-title":"The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification","volume":"4","author":"Nicoloff","year":"2019","journal-title":"Nat. Microbiol."},{"issue":"8","key":"10.1016\/j.biochi.2026.07.005_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41579-019-0218-1","article-title":"Mechanisms and clinical relevance of bacterial heteroresistance","volume":"17","author":"Andersson","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"issue":"11","key":"10.1016\/j.biochi.2026.07.005_bib13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00203-024-04173-3","article-title":"Phenotypic heterogeneity in bacteria: the rise of antibiotic persistence, clinical implications, and therapeutic opportunities","volume":"206","author":"Pani","year":"2024","journal-title":"Arch. Microbiol."},{"issue":"4","key":"10.1016\/j.biochi.2026.07.005_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00271-18","article-title":"Aminoglycoside heteroresistance in Acinetobacter baumannii AB5075","volume":"3","author":"Anderson","year":"2018","journal-title":"mSphere"},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s42003-021-02052-x","article-title":"The highly dynamic nature of bacterial heteroresistance impairs its clinical detection","volume":"4","author":"Pereira","year":"2021","journal-title":"Commun. Biol."},{"issue":"16","key":"10.1016\/j.biochi.2026.07.005_bib17","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2318600121","article-title":"Theoretical considerations and empirical predictions of the pharmaco- and population dynamics of heteroresistance","volume":"121","author":"Levin","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.biochi.2026.07.005_bib18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dkn554","article-title":"Functional relationship between bacterial cell density and the efficacy of antibiotics","volume":"63","author":"Udekwu","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01789-21","article-title":"A new pharmacokinetic-pharmacodynamic model to characterize the inoculum effect of Acinetobacter baumannii on polymyxin B in vitro","volume":"66","author":"Akrong","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biochi.2026.07.005_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-1-4939-9118-1_4","article-title":"Methods to evaluate colistin heteroresistance in Acinetobacter baumannii","author":"Sherman","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.biochi.2026.07.005_bib21","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1128\/AAC.01406-06","article-title":"Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains","volume":"51","author":"Lo-Ten-Foe","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/CMR.00058-14","article-title":"Antimicrobial heteroresistance: an emerging field in need of clarity","volume":"28","author":"El-Halfawy","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.biochi.2026.07.005_bib23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jac\/47.4.399","article-title":"A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital","volume":"47","author":"Wootton","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66118-8","article-title":"Vancomycin heteroresistance (hVISA) in MRSA links to treatment failure and supports a revised PAP-AUC threshold","volume":"16","author":"Fatsis-Kavalopoulos","year":"2025","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biochi.2026.07.005_bib25","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1128\/AAC.00103-06","article-title":"Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii","volume":"50","author":"Li","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"20","key":"10.1016\/j.biochi.2026.07.005_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics15202624","article-title":"The rapid CarbaLux combination test to uncover bacterial resistance and heteroresistance prior to antibiotic treatment","volume":"15","author":"Pfaendler","year":"2025","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib27","article-title":"High-resolution, high-throughput detection of hidden antibiotic resistance with the dilution-and-delay (DnD) susceptibility assay","volume":"17","author":"Ma","year":"2026","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.biochi.2026.07.005_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00030-25","article-title":"Improved detection of isoniazid-heteroresistant Mycobacterium tuberculosis subpopulations by droplet digital PCR compared to MeltPro TB assay","volume":"13","author":"Li","year":"2025","journal-title":"Microbiol. Spectr."},{"issue":"4","key":"10.1016\/j.biochi.2026.07.005_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biology12040525","article-title":"Heteroresistance of Mycobacterium tuberculosis in the sputum detected by droplet digital PCR","volume":"12","author":"Aung","year":"2023","journal-title":"Biology"},{"issue":"9","key":"10.1016\/j.biochi.2026.07.005_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00019-18","article-title":"Droplet digital PCR-based detection of clarithromycin resistance in Helicobacter pylori isolates reveals frequent heteroresistance","volume":"56","author":"Sun","year":"2018","journal-title":"J. Clin. Microbiol."},{"issue":"9","key":"10.1016\/j.biochi.2026.07.005_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00720-21","article-title":"Detection of pyrazinamide heteroresistance in Mycobacterium tuberculosis","volume":"65","author":"Werngren","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021958118","article-title":"Single-molecule nanopore sequencing reveals extreme target copy number heterogeneity in arylomycin-resistant mutants","volume":"118","author":"Girgis","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"27","key":"10.1016\/j.biochi.2026.07.005_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adv4558","article-title":"Droplet microfluidics-based detection of rare antibiotic-resistant subpopulations in Escherichia coli from bloodstream infections","volume":"11","author":"Agnihotri","year":"2025","journal-title":"Sci. Adv."},{"issue":"22","key":"10.1016\/j.biochi.2026.07.005_bib34","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1039\/D2LC00234E","article-title":"You will know by its tail: a method for quantification of heterogeneity of bacterial populations using single-cell MIC profiling","volume":"22","author":"Pacocha","year":"2022","journal-title":"Lab Chip"},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12670","article-title":"Helicobacter pylori heteroresistance to clarithromycin in adults-new data by in situ detection and improved concept","volume":"25","author":"Kocsm\u00e1r","year":"2020","journal-title":"Helicobacter"},{"key":"10.1016\/j.biochi.2026.07.005_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.1609863","article-title":"Efficacy of clarithromycin depends on the bacterial density in clarithromycin-heteroresistant Helicobacter pylori infections: an in situ detected susceptibility and quantitative morphometry-based retrospective study","volume":"27","author":"Kim","year":"2021","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.biochi.2026.07.005_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105618","article-title":"Machine learning detection of heteroresistance in Escherichia coli","volume":"113","author":"Guliaev","year":"2025","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41467-022-35717-0","article-title":"Resolving colistin resistance and heteroresistance in enterobacter species","volume":"14","author":"Doijad","year":"2023","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.biochi.2026.07.005_bib39","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1021\/acs.analchem.9b05387","article-title":"Heteroresistant bacteria detected by an extended raman-based antibiotic susceptibility test","volume":"92","author":"Bauer","year":"2020","journal-title":"Anal. Chem."},{"issue":"20","key":"10.1016\/j.biochi.2026.07.005_bib40","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1002\/elps.201500064","article-title":"Capillary electrophoresis for fast detection of heterogeneous population in colistin-resistant Gram-negative bacteria","volume":"36","author":"Sautrey","year":"2015","journal-title":"Electrophoresis"},{"key":"10.1016\/j.biochi.2026.07.005_bib41","article-title":"Pre-existing heterogeneity facilitates development of heteroresistance upon gene acquisition","author":"Jaggavarapu","year":"2023","journal-title":"bioRxiv"},{"issue":"7","key":"10.1016\/j.biochi.2026.07.005_bib42","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/jac\/dks084","article-title":"Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies","volume":"67","author":"Cai","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.biochi.2026.07.005_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106065","article-title":"Colistin heteroresistance in Acinetobacter spp.: systematic review and meta-analysis of the prevalence and discussion of the mechanisms and potential therapeutic implications","volume":"56","author":"Karakonstantis","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"9","key":"10.1016\/j.biochi.2026.07.005_bib44","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1007\/s00284-020-02064-6","article-title":"Polymyxin B heteroresistance and adaptive resistance in Multidrug- and extremely drug-resistant Acinetobacter baumannii","volume":"77","author":"Genteluci","year":"2020","journal-title":"Curr. Microbiol."},{"issue":"2","key":"10.1016\/j.biochi.2026.07.005_bib45","first-page":"107","article-title":"Resistance and heteroresistance to colistin among clinical isolates of Acinetobacter baumannii","volume":"67","author":"\u00c7a\u011flan","year":"2020","journal-title":"Acta Microbiol. Immunol. Hung."},{"issue":"2","key":"10.1016\/j.biochi.2026.07.005_bib46","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.diagmicrobio.2018.01.028","article-title":"Detection of colistin heteroresistance in Acinetobacter baumannii from blood and respiratory isolates","volume":"91","author":"Srinivas","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"3","key":"10.1016\/j.biochi.2026.07.005_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.05093-22","article-title":"Prevalence and clinical consequences of colistin heteroresistance and evolution into full resistance in carbapenem-resistant Acinetobacter baumannii","volume":"11","author":"Kon","year":"2023","journal-title":"Microbiol. Spectr."},{"issue":"7","key":"10.1016\/j.biochi.2026.07.005_bib48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11274-020-02873-8","article-title":"Colistin heteroresistance in carbapenem-resistant Acinetobacter baumannii clinical isolates from a Thai university hospital","volume":"36","author":"Thet","year":"2020","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10096-024-04988-4","article-title":"Incidence of colistin heteroresistance among carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Pakistan","volume":"44","author":"Zulfiqar","year":"2025","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib50","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1080\/22221751.2020.1821584","article-title":"Two types of colistin heteroresistance in Acinetobacter baumannii isolates","volume":"9","author":"Hong","year":"2020","journal-title":"Emerg. Microb. Infect."},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10010058","article-title":"Colistin dependency among colistin-heteroresistant Acinetobacter baumannii isolates","volume":"10","author":"Kon","year":"2021","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12929-023-00914-6","article-title":"Multiple heteroresistance to tigecycline and colistin in Acinetobacter baumannii isolates and its implications for combined antibiotic treatment","volume":"30","author":"Jo","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biochi.2026.07.005_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.738371","article-title":"Genotypic and phenotypic characterization of novel sequence types of carbapenem-resistant Acinetobacter baumannii, with heterogeneous resistance determinants and targeted variations in efflux operons","volume":"12","author":"Bharathi","year":"2021","journal-title":"Front. Microbiol."},{"issue":"9","key":"10.1016\/j.biochi.2026.07.005_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00788-18","article-title":"Colistin heteroresistance and involvement of the PmrAB regulatory system in Acinetobacter baumannii","volume":"62","author":"Charretier","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.biochi.2026.07.005_bib55","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41429-020-0289-2","article-title":"Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China","volume":"73","author":"Chen","year":"2020","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"4","key":"10.1016\/j.biochi.2026.07.005_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkag076","article-title":"Genomic characterization of colistin heteroresistance in Acinetobacter baumannii: evidence for lpxD deletion and collateral sensitivity","volume":"81","author":"Sancak","year":"2026","journal-title":"J. Antimicrob. Chemother."},{"issue":"36","key":"10.1016\/j.biochi.2026.07.005_bib57","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1806714115","article-title":"Phospholipid retention in the absence of asymmetry strengthens the outer membrane permeability barrier to last-resort antibiotics","volume":"115","author":"Powers","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.biochi.2026.07.005_bib58","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijantimicag.2019.08.010","article-title":"Discrepancies in susceptibility testing to colistin in Acinetobacter baumannii: the influence of slow growth and heteroresistance","volume":"54","author":"Rodriguez","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"6","key":"10.1016\/j.biochi.2026.07.005_bib59","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1099\/jmm.0.000741","article-title":"Contribution of efflux to colistin heteroresistance in a multidrug resistant Acinetobacter baumannii clinical isolate","volume":"67","author":"Machado","year":"2018","journal-title":"J. Med. Microbiol."},{"issue":"6","key":"10.1016\/j.biochi.2026.07.005_bib60","doi-asserted-by":"crossref","DOI":"10.1007\/s00284-026-04930-1","article-title":"Molecular characterizations of carbapenem resistance and colistin heteroresistance in multidrug-resistant Acinetobacter baumannii","volume":"83","author":"Omidi","year":"2026","journal-title":"Curr. Microbiol."},{"issue":"3","key":"10.1016\/j.biochi.2026.07.005_bib61","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijantimicag.2012.05.005","article-title":"Epidemiological and clinical features associated with colonisation\/infection by Acinetobacter baumannii with phenotypic heterogeneous resistance to carbapenems","volume":"40","author":"Fern\u00e1ndez-Cuenca","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"2","key":"10.1016\/j.biochi.2026.07.005_bib62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0036-46652009000200010","article-title":"Indications of carbapenem resistance evolution through heteroresistance as an intermediate stage in Acinetobacter baumannii after carbapenem administration","volume":"51","author":"Superti","year":"2009","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"issue":"4","key":"10.1016\/j.biochi.2026.07.005_bib63","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijantimicag.2010.12.015","article-title":"Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implications","volume":"37","author":"Lee","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.biochi.2026.07.005_bib64","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/JCM.05085-11","article-title":"Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii","volume":"50","author":"Hung","year":"2012","journal-title":"J. Clin. Microbiol."},{"issue":"12","key":"10.1016\/j.biochi.2026.07.005_bib65","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1128\/JCM.00959-09","article-title":"Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii","volume":"47","author":"Ikonomidis","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.biochi.2026.07.005_bib66","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijid.2017.07.005","article-title":"Isolation and whole-genome sequence analysis of the imipenem heteroresistant Acinetobacter baumannii clinical isolate HRAB-85","volume":"62","author":"Li","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.biochi.2026.07.005_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1283583","article-title":"Carbapenemase genes distribution in clonal lineages of Acinetobacter baumannii: a comprehensive study on plasmids and chromosomes","volume":"13","author":"Beig","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"6","key":"10.1016\/j.biochi.2026.07.005_bib68","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ijantimicag.2012.01.015","article-title":"Prevalence and analysis of microbiological factors associated with phenotypic heterogeneous resistance to carbapenems in Acinetobacter baumannii","volume":"39","author":"Fern\u00e1ndez Cuenca","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib69","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41598-021-04303-7","article-title":"Synergism of imipenem with fosfomycin associated with the active cell wall recycling and heteroresistance in Acinetobacter calcoaceticus-baumannii complex","volume":"12","author":"Singkham-In","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biochi.2026.07.005_bib70","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.01010-21","article-title":"Tigecycline heteroresistance and resistance mechanism in clinical isolates of Acinetobacter baumannii","volume":"9","author":"Jo","year":"2021","journal-title":"Microbiol. Spectr."},{"issue":"2","key":"10.1016\/j.biochi.2026.07.005_bib71","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/jac\/dkae436","article-title":"Resilience of tigecycline heteroresistance phenotype in Acinetobacter baumannii","volume":"80","author":"Jo","year":"2025","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.biochi.2026.07.005_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106739","article-title":"Development mechanism of resistant population post-exposure to tigecycline in tigecycline-heteroresistant Acinetobacter baumannii strain","volume":"61","author":"Jo","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biochi.2026.07.005_bib73","article-title":"Emergence of eravacycline heteroresistance in carbapenem-resistant Acinetobacter baumannii isolates in China","volume":"14","author":"Li","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"5","key":"10.1016\/j.biochi.2026.07.005_bib74","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae146","article-title":"Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections","volume":"6","author":"Shields","year":"2024","journal-title":"JAC Antimicrob. Resist"},{"key":"10.1016\/j.biochi.2026.07.005_bib75","article-title":"Carbapenem-resistant Gram-negative bacteria exhibiting clinically undetected cefiderocol heteroresistance leads to treatment failure in a murine model of infection","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.biochi.2026.07.005_bib76","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02347-22","article-title":"Acinetobacter baumannii and cefiderocol, between cidality and adaptability","volume":"10","author":"Stracquadanio","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"5","key":"10.1016\/j.biochi.2026.07.005_bib77","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(21)00194-8","article-title":"Widespread cefiderocol heteroresistance in carbapenem-resistant Gram-negative pathogens","volume":"21","author":"Choby","year":"2021","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.biochi.2026.07.005_bib78","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02371-23","article-title":"Heteroresistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii in the CREDIBLE-CR study was not linked to clinical outcomes: a post hoc analysis","volume":"11","author":"Longshaw","year":"2023","journal-title":"Microbiol. Spectr."},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib79","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1038\/s41467-025-60828-9","article-title":"Copy number flexibility facilitates heteroresistance to increasing antibiotic pressure and threatens the beta-lactam pipeline","volume":"16","author":"Choby","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biochi.2026.07.005_bib80","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s40121-025-01147-w","article-title":"From clinical trials to real-world experiences: evidence about cefiderocol use and potential role in empirical therapy","volume":"14","author":"Russo","year":"2025","journal-title":"Infect. Dis. Ther."},{"issue":"14","key":"10.1016\/j.biochi.2026.07.005_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411752","article-title":"Induced heteroresistance in carbapenem-resistant Acinetobacter baumannii (CRAB) via exposure to human pleural fluid (HPF) and its impact on cefiderocol susceptibility","volume":"24","author":"Mezcord","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biochi.2026.07.005_bib82","article-title":"Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance","volume":"11","author":"Karakonstantis","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"5","key":"10.1016\/j.biochi.2026.07.005_bib83","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02287-22","article-title":"Mechanisms of IS26-Mediated amplification of the aphA1 gene leading to tobramycin resistance in an Acinetobacter baumannii isolate","volume":"10","author":"Harmer","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"9","key":"10.1016\/j.biochi.2026.07.005_bib84","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae458","article-title":"Epidemiological, phylogenetic, and resistance heterogeneity among Acinetobacter baumannii in a large U.S. deep south healthcare system","volume":"11","author":"Graffice","year":"2024","journal-title":"Open Forum Infect. Dis."},{"issue":"7","key":"10.1016\/j.biochi.2026.07.005_bib85","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.002048","article-title":"Dissecting rifampicin heteroresistance in mycobacterium tuberculosis: integrating whole-genome sequencing with phenotypic and clonal validation","volume":"74","author":"Vallejos-Sanchez","year":"2025","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib86","article-title":"Ciprofloxacin pre-exposure influences individual cell MIC and heteroresistance of bacteria inside microfluidic droplets","volume":"15","author":"Ahmad","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biochi.2026.07.005_bib87","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01084-24","article-title":"Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis","volume":"69","author":"Vogensen","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.biochi.2026.07.005_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9061295","article-title":"Antimicrobial resistance mechanisms and virulence of Colistin- and carbapenem-resistant Acinetobacter baumannii isolated from a teaching hospital in Taiwan","volume":"9","author":"Ilsan","year":"2021","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib89","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s44259-025-00076-5","article-title":"Epidemiology, mechanisms, and clinical impact of bacterial heteroresistance","volume":"3","author":"Xu","year":"2025","journal-title":"NPJ Antimicrob. Resist."},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib90","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1038\/s41467-024-48233-0","article-title":"Three concurrent mechanisms generate gene copy number variation and transient antibiotic heteroresistance","volume":"15","author":"Nicoloff","year":"2024","journal-title":"Nat. Commun."},{"issue":"1863","key":"10.1016\/j.biochi.2026.07.005_bib91","article-title":"Reversing resistance: different routes and common themes across pathogens","volume":"284","author":"Allen","year":"2017","journal-title":"Proc. Biol. Sci."},{"issue":"2","key":"10.1016\/j.biochi.2026.07.005_bib92","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/lam.13488","article-title":"Insights into collateral susceptibility and collateral resistance in Acinetobacter baumannii during antimicrobial adaptation","volume":"73","author":"Dawan","year":"2021","journal-title":"Lett. Appl. Microbiol."},{"issue":"10","key":"10.1016\/j.biochi.2026.07.005_bib93","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/s41564-019-0480-z","article-title":"Antibiotic combinations that exploit heteroresistance to multiple drugs effectively control infection","volume":"4","author":"Band","year":"2019","journal-title":"Nat. Microbiol."},{"issue":"5","key":"10.1016\/j.biochi.2026.07.005_bib94","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02142-21","article-title":"Cefiderocol- compared to colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii","volume":"66","author":"Falcone","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.biochi.2026.07.005_bib95","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijantimicag.2016.06.006","article-title":"Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii","volume":"48","author":"Rao","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biochi.2026.07.005_bib96","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.952266","article-title":"Cefiderocol heteroresistance in NDM-producing enterobacterales: a complex polymicrobial infection successfully salvaged with ceftazidime-avibactam plus aztreonam","volume":"27","author":"Nuaimi","year":"2026","journal-title":"Am. J. Case Rep."},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib97","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12941-018-0262-0","article-title":"Comparison of nephrotoxicity of colistin with polymyxin B administered in currently recommended doses: a prospective study","volume":"17","author":"Aggarwal","year":"2018","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"issue":"2","key":"10.1016\/j.biochi.2026.07.005_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106611","volume":"60","author":"Tiseo","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib99","doi-asserted-by":"crossref","DOI":"10.2174\/0115701638253395230919112548","article-title":"Inhibitory effects of carvacrol on biofilm formation in colistin heteroresistant Acinetobacter baumannii clinical isolates","volume":"21","author":"Pakzad","year":"2024","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.biochi.2026.07.005_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103943","article-title":"A novel inhibitor of monooxygenase reversed the activity of tetracyclines against tet(X3)\/tet(X4)-positive bacteria","volume":"78","author":"Xu","year":"2022","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.biochi.2026.07.005_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105905","article-title":"In vitro efficacy of meropenem-cefmetazole combination therapy against New Delhi Metallo-\u03b2-lactamase-producing enterobacteriaceae","volume":"55","author":"Hagiya","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.biochi.2026.07.005_bib102","article-title":"Photodynamic inactivation and its effects on the heterogeneity of bacterial resistance","volume":"14","author":"Soares","year":"2024","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.biochi.2026.07.005_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13121049","article-title":"Colistin resistance mechanism and management strategies of colistin-resistant Acinetobacter baumannii infections","volume":"13","author":"Islam","year":"2024","journal-title":"Pathogens"}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908426001653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908426001653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:37:38Z","timestamp":1789054658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908426001653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":103,"alternative-id":["S0300908426001653"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2026.07.005","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in antibiotic heteroresistance in Acinetobacter baumannii","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2026.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}